114 related articles for article (PubMed ID: 3500500)
1. Generation of large granular lymphocytes and lymphocyte subset changes linked with cyclophosphamide-induced eosinophilia in rats--and the effects of ciclosporin.
Mathie IH; Sewell HF; Thomson AW
Scand J Immunol; 1987 Oct; 26(4):417-25. PubMed ID: 3500500
[TBL] [Abstract][Full Text] [Related]
2. Cyclophosphamide-induced eosinophilia in the rat: concomitant changes in T-cell subsets, B cells and large granular lymphocytes within lymphoid tissues.
Thomson AW; Mathie IH; Sewell HF
Immunology; 1987 Mar; 60(3):383-8. PubMed ID: 3494668
[TBL] [Abstract][Full Text] [Related]
3. Failure of cyclosporine A to affect generation of large granular lymphocytes (OX-8+, OX-19-) and natural killer cell activity following systemic cyclophosphamide administration and immunization in the rat.
Stewart LS; Sewell HF; Thomson AW
Transplant Proc; 1989 Feb; 21(1 Pt 1):871-2. PubMed ID: 2705253
[No Abstract] [Full Text] [Related]
4. Effects of cyclosporine A on cyclophosphamide-induced eosinophilia, concomitant B lymphocytosis, and generation of large granular lymphocytes in the rat.
Sewell HF; Mathie IH; Thomson AW
Transplant Proc; 1987 Oct; 19(5):4327-8. PubMed ID: 3499695
[No Abstract] [Full Text] [Related]
5. Inhibition of drug-induced eosinophilia by cyclosporin A.
Thomson AW; Milton JI; Aldridge RD; Davidson RJ; Simpson JG
Scand J Immunol; 1986 Aug; 24(2):163-70. PubMed ID: 3749813
[TBL] [Abstract][Full Text] [Related]
6. Increased production of Kurloff cells and accompanying lymphocyte subset changes in immunized guinea-pigs treated with cyclophosphamide and cyclosporin A.
Thomson AW; McPhee CA; Sewell HF
Immunology; 1988 Mar; 63(3):477-82. PubMed ID: 3350582
[TBL] [Abstract][Full Text] [Related]
7. Combination chemo-immunotherapy: kinetics of in vivo and in vitro generation of natural killer cells and lymphokine-activated killer cells in the rat.
Stewart LS; Sewell HF; Thomson AW
Clin Exp Immunol; 1990 Mar; 79(3):416-23. PubMed ID: 2317946
[TBL] [Abstract][Full Text] [Related]
8. Inhibition by cyclosporin A of IgE production and cyclophosphamide-induced eosinophilia in rats immunized with non-parasite antigens.
Thomson AW; Brown PA; Simpson JG; Whiting PH; Davidson RJ
Immunol Lett; 1985; 9(2-3):93-7. PubMed ID: 3872840
[TBL] [Abstract][Full Text] [Related]
9. Flow cytometric analysis of lymphocyte populations in guinea pig blood and spleen. Ia antigen expression and the effects of immunosuppressive agents.
McPhee CA; Milton JI; Thomson AW
Int Arch Allergy Appl Immunol; 1988; 87(3):275-80. PubMed ID: 2462546
[TBL] [Abstract][Full Text] [Related]
10. The influence of cyclophosphamide on antibody formation in the mouse.
Willers JM; Sluis E
Ann Immunol (Paris); 1975 Apr; 126(3):267-79. PubMed ID: 1101799
[TBL] [Abstract][Full Text] [Related]
11. Effect of cyclosporin A on lymphopoiesis. III. Augmentation of the generation of natural killer cells in bone marrow transplanted mice treated with cyclosporin A.
Kosugi A; Shearer GM
J Immunol; 1991 Mar; 146(5):1416-21. PubMed ID: 1993836
[TBL] [Abstract][Full Text] [Related]
12. Nature of the suppressor cells mediating prolonged graft survival after administration of extracted histocompatibility antigen and cyclosporine.
Yoshimura N; Kahan BD
Transplantation; 1985 Feb; 39(2):162-8. PubMed ID: 3155879
[TBL] [Abstract][Full Text] [Related]
13. Regulation of cyclophosphamide-induced eosinophilia in contact sensitivity: functional roles of interleukin-5-producing CD4(+) lymphocytes.
Sasaki G; Satoh T; Yokozeki H; Katayama I; Nishioka K
Cell Immunol; 2000 Aug; 203(2):124-33. PubMed ID: 11006010
[TBL] [Abstract][Full Text] [Related]
14. Changes in lymphocyte number and phenotype in seven lymphoid compartments after thermal injury.
Organ BC; Antonacci AC; Chiao J; Chiao J; Kumar A; de Riesthal HF; Yuan L; Black D; Calvano SE
Ann Surg; 1989 Jul; 210(1):78-89. PubMed ID: 2742415
[TBL] [Abstract][Full Text] [Related]
15. Immunosuppressive activity of FK-506 in rats: flow cytometric analysis of lymphocyte populations in blood, spleen and thymus during treatment and following drug withdrawal.
Woo J; Ross CS; Milton JI; Thomson AW
Clin Exp Immunol; 1990 Jan; 79(1):109-14. PubMed ID: 1689226
[TBL] [Abstract][Full Text] [Related]
16. Immunosuppressive activity and toxicity of cyclosporin A in rats pretreated with high dose cyclophosphamide.
Brown PA; Thomson AW; Whiting PH; Davidson RJ; Simpson JG
Agents Actions; 1985 Oct; 17(1):67-72. PubMed ID: 4083181
[TBL] [Abstract][Full Text] [Related]
17. Effects of cyclophosphamide treatment on the in vitro activity of mouse lymphoid cells after nonspecific and specific stimulation.
Snippe H; Davidse RP; Belder M; Willers JM
Int Arch Allergy Appl Immunol; 1976; 50(5):536-47. PubMed ID: 1083834
[TBL] [Abstract][Full Text] [Related]
18. Influence of FK506 and cyclosporin A on alloantibody production and lymphocyte activation following blood transfusion.
Woo J; Propper DJ; Macleod AM; Thomson AW
Clin Exp Immunol; 1990 Dec; 82(3):462-8. PubMed ID: 1702375
[TBL] [Abstract][Full Text] [Related]
19. The effect of cyclophosphamide in vivo on the expression of lymphocyte markers, detected by monoclonal antibodies, in the rat.
el-Sady E; Parker D; Turk JL
Int J Immunopharmacol; 1986; 8(8):961-6. PubMed ID: 2879804
[TBL] [Abstract][Full Text] [Related]
20. Induction of a marked eosinophilia by cyclophosphamide in Toxocara canis infected SJL mice.
Sugane K; Oshima T
Parasite Immunol; 1985 May; 7(3):255-63. PubMed ID: 4011300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
